Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.7 USD | -22.95% | 0.00% | 0.00% |
May. 24 | Hong Kong Shares End Week in Red; Sunho Biologics Gains in Debut | MT |
May. 24 | Akeso Lung Cancer Drug Gets NMPA's Marketing Approval; Stocks Crash 20% | MT |
Sales 2024 * | 2.64B 364M | Sales 2025 * | 4.23B 584M | Capitalization | 27.55B 3.8B |
---|---|---|---|---|---|
Net income 2024 * | -441M -60.84M | Net income 2025 * | 233M 32.15M | EV / Sales 2024 * | 11.1 x |
Net Debt 2024 * | 1.71B 236M | Net Debt 2025 * | 420M 58.01M | EV / Sales 2025 * | 6.61 x |
P/E ratio 2024 * |
-59.4
x | P/E ratio 2025 * |
113
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 73.33% |
3 months | -19.80% |
Managers | Title | Age | Since |
---|---|---|---|
Baiyong Li
FOU | Founder | 56 | 12-03-18 |
Peng Zhang
FOU | Founder | 48 | 12-03-18 |
Michelle Xia
CEO | Chief Executive Officer | 58 | 12-03-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bo Tan
BRD | Director/Board Member | 51 | 20-03-31 |
Zhongmin Wang
FOU | Founder | 55 | 12-03-18 |
Yan Xu
BRD | Director/Board Member | 61 | 20-03-31 |
Date | Price | Change |
---|---|---|
24-05-24 | 4.7 | +∞% |
24-05-23 | - | -100.00% |
Delayed Quote OTC Markets, May 24, 2024 at 03:14 pm EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.83% | 115B | |
+10.80% | 105B | |
-10.84% | 22.71B | |
-1.31% | 21.83B | |
-10.88% | 18.18B | |
-41.92% | 16.52B | |
-15.11% | 16.01B | |
+6.62% | 14.14B | |
+17.53% | 10.71B |
- Stock Market
- Equities
- 9926 Stock
- AKESF Stock